Axsome Therapeutics Inc (AXSM)
Sector • Healthcare Industry • Major Pharmaceutical Preparations |
Industry • Major Pharmaceutical Preparations |
Sector • Healthcare |
News
Axsome Therapeutics Inc Achieves Record Revenue Growth of 243.077% in Q3 2023
The Deficit has widen at the Axsome Therapeutics Inc during the second quarter of 2023
Axsome Therapeutics Inc. Achieves Impressive Revenue of $94.576 Million in Latest Fiscal Period
The company published Revenue of $24.371528 millions, in the October to December 31 2022
published Revenue of $16.845792 millions, in the July to September 30 2022